loader
Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (KDMF) for Deferasirox Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Deferasirox

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 408Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 FARMAK, a.s
    Czech Republic
    		 Geonil Pharmaceutical Co., Ltd. No. 2816-7-ND(1) Deferasirox 2017-07-27 Farmak, as Czech Republic Na vlcinci 16/3, Klasterni Hradisko, 779 00 Olomouc, Czech Republic
    28/09/2024 Neuland Laboratories
    India
    		 Aging Life Science Co., Ltd. Su434-12-ND Deferasirox 2020-06-30 Neuland Laboratories Limited (Unit-II) India Plot No. 92-94, 257-259 IDA, Pashamylaram, Isnapur Village, Patancheru Mandal, Sangareddy District - 502319 Telangana State, India